Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Gross Profit | N/A | N/A | N/A | N/A | 35,020 |
| Operating Expenses | 37,025 | 70,197 | 0 | 0 | 17,650 |
| Operating Income | -37,025 | -70,197 | N/A | N/A | -17,650 |
| Other Income | -2,733 | 1,358 | 0 | 0 | 0 |
| Pre-tax Income | -39,758 | -68,839 | 0 | 0 | -17,650 |
| Income Tax | 813 | -20 | N/A | N/A | N/A |
| Net Income Continuous | -40,571 | -68,819 | N/A | N/A | -17,650 |
| Minority Interests | -518 | -208 | N/A | N/A | N/A |
| Net Income | $-40,053 | $-68,611 | $N/A | $N/A | $-17,650 |
| EPS Basic Total Ops | -102.93 | -374.39 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -142.35 | -375.52 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -102.93 | -374.39 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -142.35 | -375.52 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -102.93 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-36,594 | $-70,042 | $N/A | $N/A | $-14,510 |